Dr. Baine is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
42nd And Emile
Omaha, NE 68198- Is this information wrong?
Summary
- I am a member of the Department of Radiation Oncology at the University of Nebraska Medical Center, acting in a physician scientist role. My clinical practice is focused on GU malignancies with my lab investigating pancreas, prostate, and bladder cancers. I have specific interests in radiomics, ultrahypofractionated radiation treatment for prostate, body SBRT for oligometastatic diseases, and the interactions between high dose-per-fraction radiation treatments and the immune system with the hope of leveraging this into greater efficacy of immunotherapy.
Education & Training
- University of Nebraska Medical Center College of MedicineResidency, Radiation Oncology, 2015 - 2019
- University of Nebraska Medical Center College of MedicineInternship, Internal Medicine, 2014 - 2015
- University of Nebraska College of Medicine
Certifications & Licensure
- NE State Medical License 2019 - 2024
- IA State Medical License 2019 - 2024
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Sigma Xi 2022
- Alpha Sigma Nu Loyola Marymount University, 2006
- Inductee Alpha Omega Alpha Honor Medical Society
Clinical Trials
- Hypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic Cancer Start of enrollment: 2016 Sep 16
- Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer Start of enrollment: 2019 Jun 03
- Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial Start of enrollment: 2020 Dec 15
- Join now to see all
Publications & Presentations
PubMed
- Predictive Value of Multiparametric Magnetic Resonance Imaging in Risk Group Stratification of Prostate Adenocarcinoma.Benjamin T Bonebrake, Elsa Parr, Linda My Huynh, Neil Hansen, Chad Lagrange, Brendan Coutu, Benjamin Teply, Charles Enke, Michael Baine> ;Advances in Radiation Oncology. 2024 Jun 1
- Multi-Institutional Development and Validation of a Radiomic Model to Predict Prostate Cancer Recurrence Following Radical Prostatectomy.Huynh, L., Bonebrake, B., Tran, J., Marasco, J., Wang, S., Ahlering, T., Baine, M.> ;Journal of Clinical Medicine. 2023 Nov 26
- 1 citations3DGAUnet: 3D Generative Adversarial Networks with a 3D U-Net Based Generator to Achieve the Accurate and Effective Synthesis of Clinical Tumor Image Data for Pancreati...Shi, Y., Tang, H., Hollingsworth, M., Du, H., Zheng, D., Zhang, C., Baine, M., Yu, H.> ;Cancers. 2023 Nov 21
- Join now to see all
Press Mentions
- The Impact of Neoadjuvant and Adjuvant Immunotherapy on the Survival of Pancreatic Cancer Patients: A Retrospective AnalysisJune 9th, 2020
- The Impact of Immunotherapy on the Survival of Pancreatic Adenocarcinoma Patients Who Received Definitive Surgery of the Pancreatic Tumor: A Retrospective Analysis of the National Cancer DatabaseJune 3rd, 2020
Professional Memberships
- Member
- Member
- Member
- Member
Hospital Affiliations
- The Nebraska Medical CenterOmaha, Nebraska
- Nebraska Medicine - Nebraska Medical CenterOmaha, Nebraska
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: